Novel anti-angiogenetic agents developing in China.
Ding
Jian
J
Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 294 Taiyuan Road, Shanghai 200031, China. jding@mail.shcnc.ac.cn
Zhen
Yongsu
Y
Tong
Yunguang
Y
Yue
Jianmin
J
Xiao
Dong
D
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D004224:Diterpenes / Q000494:pharmacology; D000949:Histocompatibility Antigens Class II; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000473:pathology; D014407:Tumor Cells, Cultured
D020533:Angiogenesis Inhibitors; D000972:Antineoplastic Agents, Phytogenic; C088544:DYB antigen; D004224:Diterpenes; D000949:Histocompatibility Antigens Class II; C058390:pseudolaric acid A